Sirius Biotech Ventures

Website
BioTech

Company Bio

Founders

LvlUp insightsGenerated from LvlUp’s portfolio data and the company’s own updates
Similar companies

More in the LvlUp portfolio

See all →

Building something ambitious?

LvlUp Ventures backs founders from first check to late stage.

Apply for funding
Frantz Jean-Francois
Pre-Seed
United States
BioTech
2024
Sirius discovers drug candidates that overcome resistance to KRAS cancer therapies. We develop and validate these candidates to preclinical proof of concept, then partner with or license them to oncology-focused pharmaceutical companies.

Sirius Biotech Ventures discovers companion drugs that extend responses to KRAS cancer therapies. Our platform maps how tumors adapt to treatment and identifies molecules that block resistance, creating new combination therapies for lung, colorectal, and pancreatic cancers.